Roivant Sciences Ltd. Roivant Sciences Ltd.

Roivant Sciences Ltd.

ROIV

Rangering i aksjer #978
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Aksjekurs
$33.73
Sist synkronisert: 2026-07-31
Markedsverdi
$24.37B
Endring (1 dag)
-2.28%
Endring (1 år)
95.44%
Land
GB
Handel Roivant Sciences Ltd. (ROIV)

Kategori

Healthcare
Driftsmargin for Roivant Sciences Ltd. (ROIV)
Driftsmargin per October 2026 TTM: -18,140.92%
Ifølge Roivant Sciences Ltd. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) -18,140.92%. Ved slutten av 2024 hadde selskapet en driftsmargin på 3,399.19%.
Historikk for driftsmargin for Roivant Sciences Ltd. fra 2020 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) -18,140.92% 425.32%
2025 -3,453.32% -201.59%
2024 3,399.19% -277.23%
2023 -1,917.95% -21.55%
2022 -2,444.82% -45.68%
2021 -4,500.52% 472.16%
2020 -786.58% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
38.59% -100.00%
US
-149.01% -99.99%
US
25.57% -100.00%
AU
0.00% -
CH
28.81% -100.00%
NL
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.